A scientific study published 21st April 2022, concluded that Covid-19 vaccination can elicit a distinct T cell-dominant immune-mediated hepatitis (liver inflammation) with a unique pathomechanism associated with vaccination-induced antigen-specific tissue-resident immunity requiring systemic immunosuppression.
In Layman’s terms, the scientists discovered that liver inflammation (hepatitis) can occur in some individuals